15 results
8-K
EX-99.1
INSM
Insmed Incorporated
5 Aug 21
Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update
7:30am
pharmacokinetic/pharmacodynamic multiple-dose study is now underway.
TPIP
Insmed expects to present data from the Phase 1 healthy volunteer trial
8-K
EX-99.1
INSM
Insmed Incorporated
6 May 21
Insmed Reports First Quarter 2021 Financial Results and Provides Business Update
7:30am
anticipates that topline data will be shared in the second quarter of 2021.
TPIP
Following positive data from the Phase 1 healthy volunteer trial
8-K
EX-99.1
ubxi6
25 Feb 21
Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:29am
8-K
EX-99.1
jbjj qmq7r6y079yc1
19 Feb 21
Regulation FD Disclosure
9:09am
8-K
gibyu v8teayer1bp3ep
19 Feb 21
Regulation FD Disclosure
9:09am
8-K
EX-99.1
u3c7gu2ke667ldwp sf
29 Oct 20
Insmed Reports Third Quarter 2020 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
qx21a pk9ovgd
1 Oct 20
Insmed Highlights Progress Across Portfolio and Outlines Growth Strategy at R&D Day
12:00am
- Prev
- 1
- Next